Literature DB >> 26165831

Proton pump inhibitors and risk of hypomagnesemia.

Luca Pasina1, Danilo Zanotta2, Silvana Puricelli2, Djade Codjo Djignefa3, Guido Bonoldi2.   

Abstract

Entities:  

Keywords:  Adverse drug reaction; Hypomagnesemia; Pharmacoepidemiology; Proton pump inhibitors

Mesh：

Substances：

Year:  2015        PMID： 26165831     DOI： 10.1016/j.ejim.2015.06.019

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  6 in total

1.  Acute neurological symptoms secondary to hypomagnesemia induced by proton pump inhibitors: a case series.

Authors:  Luca Pasina; Danilo Zanotta; Silvana Puricelli; Guido Bonoldi
Journal:  Eur J Clin Pharmacol       Date:  2016-02-13       Impact factor: 2.953

2.  Seizure and tetany secondary to hypomagnesaemic hypoparathyroidism induced by a proton-pump inhibitor.

Authors:  Luca Pasina; Danilo Zanotta; Silvana Puricelli; Guido Bonoldi
Journal:  Eur J Clin Pharmacol       Date:  2016-11-28       Impact factor: 2.953

3.  Assessing the Impact on Health of Pharmacovigilance Activities: Example of Four Safety Signals.

Authors:  Florence van Hunsel; Laura Peters; Helga Gardarsdottir; Agnes Kant
Journal:  Drug Saf       Date:  2021-02-19       Impact factor: 5.606

4.  Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies.

Authors:  Thawin Srinutta; Api Chewcharat; Kullaya Takkavatakarn; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 5.  Mechanisms of proton pump inhibitor-induced hypomagnesemia.

Authors:  Lisanne M M Gommers; Joost G J Hoenderop; Jeroen H F de Baaij
Journal:  Acta Physiol (Oxf)       Date:  2022-06-14       Impact factor: 7.523

Review 6.  Therapeutic Efficacy of Kangfuxin Liquid Combined with PPIs in Gastric Ulcer.

Authors:  Jun-Bo Zou; Xiao-Fei Zhang; Ya-Jun Shi; Jia Tai; Yu Wang; Yu-Lin Liang; Fang Wang; Jiang-Xue Cheng; Jing Wang; Dong-Yan Guo
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-30       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.